Ardian acquire a stake in IVB Wellness Lab: Advisors

Ardian has signed an agreement to acquire a stake in IVB Wellness Lab, a Spanish company specialising in the research, development and distribution of science-based food supplements. With this investment, Ardian’s growth team is partnering with IVB’s founding team and current minority shareholder Label Capital to accelerate IVB’s expansion in Spain and across Europe.

IVB Wellness Lab

Founded in 2021 by Isabel Viña Bas, Valerio Soto Ferri and Carlos Viña Bas, IVB has established itself as one of Spain’s most dynamic dietary supplement brands, operating in a market driven by sustainable consumer trends around lifestyle and health. Headquartered in Valencia, IVB differentiates itself through the sourcing of specific ingredients and a unique approach that includes clinical oversight and partnerships with hospitals.

Based on an asset-light model, IVB offers a range of products spanning from essential dietary supplements (e.g., magnesium, omega 3) to advanced formulas targeting areas of general wellbeing, such as women’s health. Initially launched as a digital D2C (direct-to-consumer) brand, IVB has developed a strong and engaged community and has experienced industry-leading revenue growth. IVB has also rapidly expanded into the pharmaceutical channel, now reaching some 2,000 pharmacies throughout Spain.

The transaction is expected to close in the first quarter of 2026.

Advisors

Ardian was advised by a team from Garrigues in Madrid. Specifically, José Luis Ortín Romero, Luis Enrique Mata Palacios and Marta Ocón Barceló.

Label Capital was advised by a team from EY Abogados: Javier Bustillo, Manuel Paz and Santiago López.

IVB Well Lab was advised by a team from Garrigues in Valencia. Specifically, Alejandro Micó Llorens, Paula Crespo and Ester García Camps.